AAAAAA

   
Results: 1-25 | 26-44
Results: 1-25/44
LACK OF MULTIPLE DOSING EFFECT OF SERTINDOLE ON THE PHARMACOKINETICS OF ALPRAZOLAM IN HEALTHY-VOLUNTEERS
Authors: WONG SL LOCKE C STASER J GRANNEMAN GR
Citation: Sl. Wong et al., LACK OF MULTIPLE DOSING EFFECT OF SERTINDOLE ON THE PHARMACOKINETICS OF ALPRAZOLAM IN HEALTHY-VOLUNTEERS, Psychopharmacology, 135(3), 1998, pp. 236-241
LACK OF CYP3A INHIBITION EFFECTS OF SERTINDOLE ON TERFENADINE IN HEALTHY-VOLUNTEERS
Authors: WONG SL CAO G MACK R GRANNEMAN GR
Citation: Sl. Wong et al., LACK OF CYP3A INHIBITION EFFECTS OF SERTINDOLE ON TERFENADINE IN HEALTHY-VOLUNTEERS, International journal of clinical pharmacology and therapeutics, 36(3), 1998, pp. 146-151
RITONAVIR - CLINICAL PHARMACOKINETICS AND INTERACTIONS WITH OTHER ANTI-HIV AGENTS
Authors: HSU A GRANNEMAN GR BERTZ RJ
Citation: A. Hsu et al., RITONAVIR - CLINICAL PHARMACOKINETICS AND INTERACTIONS WITH OTHER ANTI-HIV AGENTS, Clinical pharmacokinetics, 35(4), 1998, pp. 275-291
EFFECT OF RITONAVIR ON THE PHARMACOKINETICS OF ETHINYL ESTRADIOL IN HEALTHY FEMALE VOLUNTEERS
Authors: OUELLET D HSU A QIAN J LOCKE CS EASON CJ CAVANAUGH JH LEONARD JM GRANNEMAN GR
Citation: D. Ouellet et al., EFFECT OF RITONAVIR ON THE PHARMACOKINETICS OF ETHINYL ESTRADIOL IN HEALTHY FEMALE VOLUNTEERS, British journal of clinical pharmacology, 46(2), 1998, pp. 111-116
RECENT DEVELOPMENTS IN HIV PROTEASE INHIBITOR THERAPY
Authors: MOLLA A GRANNEMAN GR SUN E KEMPF DJ
Citation: A. Molla et al., RECENT DEVELOPMENTS IN HIV PROTEASE INHIBITOR THERAPY, Antiviral research, 39(1), 1998, pp. 1-23
PHARMACOKINETIC INTERACTION BETWEEN RITONAVIR AND INDINAVIR IN HEALTHY-VOLUNTEERS
Authors: HSU A GRANNEMAN GR CAO GL CAROTHERS L JAPOUR A ELSHOURBAGY T DENNIS S BERG J ERDMAN K LEONARD JM SUN EG
Citation: A. Hsu et al., PHARMACOKINETIC INTERACTION BETWEEN RITONAVIR AND INDINAVIR IN HEALTHY-VOLUNTEERS, Antimicrobial agents and chemotherapy, 42(11), 1998, pp. 2784-2791
POPULATION ANALYSIS OF THE PHARMACOKINETICS OF TIAGABINE IN PATIENTS WITH EPILEPSY
Authors: SAMARA EE GUSTAVSON LE ELSHOURBAGY T LOCKE C GRANNEMAN GR SOMMERVILLE KW
Citation: Ee. Samara et al., POPULATION ANALYSIS OF THE PHARMACOKINETICS OF TIAGABINE IN PATIENTS WITH EPILEPSY, Epilepsia, 39(8), 1998, pp. 868-873
PHARMACOKINETIC INTERACTION BETWEEN RITONAVIR AND CLARITHROMYCIN
Authors: OUELLET D HSU A GRANNEMAN GR CARLSON G CAVANAUGH J GUENTHER H LEONARD JM
Citation: D. Ouellet et al., PHARMACOKINETIC INTERACTION BETWEEN RITONAVIR AND CLARITHROMYCIN, Clinical pharmacology and therapeutics, 64(4), 1998, pp. 355-362
PHARMACOKINETIC INTERACTIONS BETWEEN 2 HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE INHIBITORS, RITONAVIR AND SAQUINAVIR
Authors: HSU A GRANNEMAN GR CAO GL CAROTHERS L ELSHOURBAGY T BAROLDI P ERDMAN K BROWN F SUN E LEONARD JM
Citation: A. Hsu et al., PHARMACOKINETIC INTERACTIONS BETWEEN 2 HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE INHIBITORS, RITONAVIR AND SAQUINAVIR, Clinical pharmacology and therapeutics, 63(4), 1998, pp. 453-464
EFFECT OF RITONAVIR ON CYP1A2, 2C19, AND 2E1 ACTIVITIES IN-VIVO
Authors: FRYE RF BERTZ RJ GRANNEMAN GR LAUVA I LAMM J DENNIS S VALDES J
Citation: Rf. Frye et al., EFFECT OF RITONAVIR ON CYP1A2, 2C19, AND 2E1 ACTIVITIES IN-VIVO, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 44-44
SINGLE-DOSE, STEADY-STATE PHARMACOKINETICS OF SERATRODAST (AA-2414) IN HEALTHY MALE AND FEMALE VOLUNTEERS
Authors: SAMARA EE QIAN J LOCKE C DEAN R KILLIAN A GRANNEMAN GR
Citation: Ee. Samara et al., SINGLE-DOSE, STEADY-STATE PHARMACOKINETICS OF SERATRODAST (AA-2414) IN HEALTHY MALE AND FEMALE VOLUNTEERS, Clinical drug investigation, 14(6), 1997, pp. 494-501
USE OF IN-VITRO AND IN-VIVO DATA TO ESTIMATE THE LIKELIHOOD OF METABOLIC PHARMACOKINETIC INTERACTIONS
Authors: BERTZ RJ GRANNEMAN GR
Citation: Rj. Bertz et Gr. Granneman, USE OF IN-VITRO AND IN-VIVO DATA TO ESTIMATE THE LIKELIHOOD OF METABOLIC PHARMACOKINETIC INTERACTIONS, Clinical pharmacokinetics, 32(3), 1997, pp. 210-258
SERTINDOLE IN THE TREATMENT OF PSYCHOSIS IN SCHIZOPHRENIA - EFFICACY AND SAFETY
Authors: TAMMINGA CA MACK RJ GRANNEMAN GR SILBER CJ KASHKIN KB
Citation: Ca. Tamminga et al., SERTINDOLE IN THE TREATMENT OF PSYCHOSIS IN SCHIZOPHRENIA - EFFICACY AND SAFETY, International clinical psychopharmacology, 12, 1997, pp. 29-35
EFFECTS OF FOOD, ANTACID, AND DOSAGE FORM ON THE PHARMACOKINETICS ANDRELATIVE BIOAVAILABILITY OF SERTINDOLE IN HEALTHY-VOLUNTEERS
Authors: WONG SL LINNEN P MACK R GRANNEMAN GR
Citation: Sl. Wong et al., EFFECTS OF FOOD, ANTACID, AND DOSAGE FORM ON THE PHARMACOKINETICS ANDRELATIVE BIOAVAILABILITY OF SERTINDOLE IN HEALTHY-VOLUNTEERS, Biopharmaceutics & drug disposition, 18(6), 1997, pp. 533-541
THE EFFECT OF ERYTHROMYCIN ON THE CYP3A COMPONENT OF SERTINDOLE CLEARANCE IN HEALTHY-VOLUNTEERS
Authors: WONG SL CAO GL MACK RJ GRANNEMAN GR
Citation: Sl. Wong et al., THE EFFECT OF ERYTHROMYCIN ON THE CYP3A COMPONENT OF SERTINDOLE CLEARANCE IN HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 37(11), 1997, pp. 1056-1061
MULTIPLE-DOSE PHARMACOKINETICS OF RITONAVIR IN HUMAN IMMUNODEFICIENCYVIRUS-INFECTED SUBJECTS
Authors: HSU A GRANNEMAN GR WITT G LOCKE C DENISSEN J MOLLA A VALDES J SMITH J ERDMAN K LYONS N NIU P DECOURT JP FOURTILLAN JB GIRAULT J LEONARD JM
Citation: A. Hsu et al., MULTIPLE-DOSE PHARMACOKINETICS OF RITONAVIR IN HUMAN IMMUNODEFICIENCYVIRUS-INFECTED SUBJECTS, Antimicrobial agents and chemotherapy, 41(5), 1997, pp. 898-905
PHARMACOKINETIC ENHANCEMENT OF INHIBITORS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE BY COADMINISTRATION WITH RITONAVIR
Authors: KEMPF DJ MARSH KC KUMAR G RODRIGUES AD DENISSEN JF MCDONALD E KUKULKA MJ HSU A GRANNEMAN GR BAROLDI PA SUN E PIZZUTI D PLATTNER JJ NORBECK DW LEONARD JM
Citation: Dj. Kempf et al., PHARMACOKINETIC ENHANCEMENT OF INHIBITORS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE BY COADMINISTRATION WITH RITONAVIR, Antimicrobial agents and chemotherapy, 41(3), 1997, pp. 654-660
PHARMACOKINETICS OF SERTINDOLE AND DEHYDROSERTINDOLE IN VOLUNTEERS WITH NORMAL OR IMPAIRED RENAL-FUNCTION
Authors: WONG SL MENACHERRY S MULFORD D SCHMITZ PJ LOCKE C GRANNEMAN GR
Citation: Sl. Wong et al., PHARMACOKINETICS OF SERTINDOLE AND DEHYDROSERTINDOLE IN VOLUNTEERS WITH NORMAL OR IMPAIRED RENAL-FUNCTION, European Journal of Clinical Pharmacology, 52(3), 1997, pp. 223-227
A SINGLE-DOSE STUDY TO DEFINE TIAGABINE PHARMACOKINETICS IN PEDIATRIC-PATIENTS WITH COMPLEX PARTIAL SEIZURES
Authors: GUSTAVSON LE BOELLNER SW GRANNEMAN GR QIAN JX GUENTHER HJ ELSHOURBAGY T SOMMERVILLE KW
Citation: Le. Gustavson et al., A SINGLE-DOSE STUDY TO DEFINE TIAGABINE PHARMACOKINETICS IN PEDIATRIC-PATIENTS WITH COMPLEX PARTIAL SEIZURES, Neurology, 48(4), 1997, pp. 1032-1037
POPULATION ANALYSIS OF THE PHARMACOKINETICS AND PHARMACODYNAMICS OF SERATRODAST IN PATIENTS WITH MILD-TO-MODERATE ASTHMA
Authors: SAMARA E CAO GL LOCKE C GRANNEMAN GR DEAN R KILLIAN A
Citation: E. Samara et al., POPULATION ANALYSIS OF THE PHARMACOKINETICS AND PHARMACODYNAMICS OF SERATRODAST IN PATIENTS WITH MILD-TO-MODERATE ASTHMA, Clinical pharmacology and therapeutics, 62(4), 1997, pp. 426-435
PHARMACOKINETICS OF SERTINDOLE IN HEALTHY-YOUNG AND ELDERLY MALE AND FEMALE SUBJECTS
Authors: WONG SL CAO GL MACK RJ GRANNEMAN GR
Citation: Sl. Wong et al., PHARMACOKINETICS OF SERTINDOLE IN HEALTHY-YOUNG AND ELDERLY MALE AND FEMALE SUBJECTS, Clinical pharmacology and therapeutics, 62(2), 1997, pp. 157-164
POPULATION PHARMACOKINETICS OF SERTINDOLE IN PATIENTS WITH SCHIZOPHRENIA
Authors: OUELLET D CAO G STASER J GRANNEMAN GR
Citation: D. Ouellet et al., POPULATION PHARMACOKINETICS OF SERTINDOLE IN PATIENTS WITH SCHIZOPHRENIA, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 50-50
ORDERED ACCUMULATION OF MUTATIONS IN HIV PROTEASE CONFERS RESISTANCE TO RITONAVIR
Authors: MOLLA A KORNEYEVA M GAO Q VASAVANONDA S SCHIPPER PJ MO HM MARKOWITZ M CHERNYAVSKIY T NIU P LYONS N HSU A GRANNEMAN GR HO DD BOUCHER CAB LEONARD JM NORBECK DW KEMPF DJ
Citation: A. Molla et al., ORDERED ACCUMULATION OF MUTATIONS IN HIV PROTEASE CONFERS RESISTANCE TO RITONAVIR, Nature medicine, 2(7), 1996, pp. 760-766
PHARMACOKINETICS OF RITONAVIR-SAQUINAVIR COMBINATION THERAPY
Authors: CAMERON DW HSU A GRANNEMAN GR SUN E MCMAHON D FARTHING C PORETZ D MARKOWTIZ M COHEN C FOLLANSBEE S MELLORS J HO D XU Y RODE R SALGO M LEONARD J
Citation: Dw. Cameron et al., PHARMACOKINETICS OF RITONAVIR-SAQUINAVIR COMBINATION THERAPY, AIDS, 10, 1996, pp. 56-56
PHARMACOKINETIC INTERACTIONS AND SIDE-EFFECTS RESULTING FROM CONCOMITANT ADMINISTRATION OF LITHIUM AND DIVALPROEX SODIUM
Authors: GRANNEMAN GR SCHNECK DW CAVANAUGH JH WITT GF
Citation: Gr. Granneman et al., PHARMACOKINETIC INTERACTIONS AND SIDE-EFFECTS RESULTING FROM CONCOMITANT ADMINISTRATION OF LITHIUM AND DIVALPROEX SODIUM, The Journal of clinical psychiatry, 57(5), 1996, pp. 204-206
Risultati: 1-25 | 26-44